EndeavorRx Insight® v1.2.1

Experience your child's journey through the EndeavorRx treatment with EndeavorRx Insight. This official companion app for parents allows you to stay connected by providing a daily overview of your child's in-game mission completion and effort score.

Key Features:

• Focus Score: Track your child's attention progress with a personalized score.
• View Mission Completion: Easily see if your child has completed all their daily play, helping them stay on track.
• Monitor Daily Effort: Gain insight into your child's level of effort and adherence to the game's rules through in-game interaction analysis.
• Track Symptoms: Utilize the caregiver assessment consisting of 21 questions to monitor and assess symptoms.
• Treatment Recommendations: Access the Essentials for Caregivers course, which equips you with the knowledge needed to seamlessly integrate EndeavorRx treatment into your family's daily routine during the initial month of treatment.
• Export Reports: Generate comprehensive reports and share them with your child's healthcare provider to facilitate informed conversations and treatment planning.
• Get Support: If you encounter any issues, the app provides a direct connection to our Akili Assist support team.

Please note: EndeavorRx Insight requires an active prescription for EndeavorRx digital treatment and an internet connection for your child to use the app.

About EndeavorRx:

EndeavorRx is the first and only FDA-authorized video game treatment specifically designed for children aged 8-12 with ADHD-related inattention. This innovative treatment requires a prescription from a healthcare provider and is developed by leading neuroscientists and award-winning game designers. Powered by the Selective Stimulus Management Engine (SSME™) technology, EndeavorRx effectively engages and challenges specific areas of the brain critical for attention function.

For more information, scheduling virtual appointments with doctors, or obtaining advice on discussing EndeavorRx with your current healthcare provider, please visit EndeavorRx.com.

Indications for Use:

EndeavorRx is a digital therapeutic intended to improve attention function in children aged 8-12 diagnosed with primarily inattentive or combined-type ADHD, and who exhibit demonstrable attention issues. Patients engaging with EndeavorRx have shown improvements in computer-based testing of sustained and selective attention, as measured by the Test of Variables of Attention (TOVA®). It is important to note that this treatment may not directly address typical behavioral symptoms such as hyperactivity and should be considered along with other therapeutic approaches including clinician-directed therapy, medication, and educational programs.

Side Effects:

No serious adverse events have been reported. Among the 538 participants involved in trials supporting the authorization of EndeavorRx, 50 individuals (9.3%) experienced probable or likely treatment-related adverse events. In studies involving a control group, three participants reported treatment-related adverse events associated with the digital control. Adverse events included frustration (6.1%), headache (1.3%), dizziness (0.6%), emotional reaction (0.4%), nausea (0.4%), and aggression (0.2%). These adverse events were generally temporary in nature, with only three cases resulting in device discontinuation. No lasting or irreversible effects were reported after discontinuation.

Akili, EndeavorRx, Endeavor, Akili Care, ADHD Insight, Insight, EndeavorRx Insight, SSME, Play Your Medicine, and Akili Assist, as well as the respective logos, are trademarks or registered trademarks of Akili Interactive Labs, Inc. Other trademarks mentioned belong to their respective owners. Relevant patent protection information for EndeavorRx can be found in the Terms of Use provided below.

Terms of Use: https://my.akili.care/terms

Privacy Notice: https://my.akili.care/privacy